Blog

Science 37 Forecast—The Adoption of Hybrid Oncology Trials Will Accelerate in 2023 & Beyond

Author: Dr. Shaalan Beg, Vice President, Oncology Oncology is a therapeutic area of singular importance…

Blog

What Clinical Trial Patient Participants Want

Author: Darcy Forman, Chief Delivery Officer, Science 37 In clinical trials, participant satisfaction is critical…

Report

Clinical Decision Makers Confirm a Shift to Hybrid and Decentralized Studies

Clinical research is undergoing transformation across the board—but how will it impact oncology clinical trials?…

Webinar

Decentralization in Action: What Oncology Trials Look Like Now

What current clinical research looks like with oncology trials

Webinar

What Clinical Trial Participants Want — And How Sponsors can Deliver

Science 37 carefully examines all clinical trial options and elements needed for research — helping…

Report

Decentralized Clinical Trials — Is There a Positive Return on Investment on a Virtual Site?

Across the Life Sciences industry, there has been much talk about the cost and value…

Webinar

Webinar—How Decentralized Clinical Trials are Impacting Research

Learn more about agile technologies and industry standards that are needed to drive clinical trial…

Report

How Decentralized and Hybrid Trials are Impacting Clinical Research

Science 37’s 2nd Annual The Future of Clinical Trials Survey shares how the acceleration and…

Report

How to Meet the FDA Diversity Action Plan Guidance

The pending FDA Guideline’s intention is clear—pharma companies must plan, report and collaborate to improve…

Webinar

Increasing Participation of Women in Oncology Clinical Trials

There are low numbers of women in oncology clinical trials. Why aren’t more women represented?

Report

Why Migraine and Other Headache Disorders Are a Good Fit for Decentralized Clinical Trials

Characterized by recurring episodes of moderate to severe headache, elevated sensitivity to sound and/or light…

Webinar

Oncology Clinical Trials: How Hybrid Approaches are Changing The Clinical Landscape

Is your oncology clinical trial prepared for the next generation of trial methodologies?